AstraZeneca asks US drug regulator to authorise Covid antibody treatment
AstraZeneca has asked the US Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent Covid-19.
The Anglo-Swedish drug maker, which developed one of the first Covid vaccines, said the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorisation for Covid-19 prevention.
